Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: A role in ovarian pathogenesis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Oncology

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molonc.2008.05.001PMID 19383336PMCID PMC2598416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: A role in ovarian pathogenesis

  2008cited by this paper
• Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-β Signaling*

  2007cited by this paper
• Arkadia Activates Smad3/Smad4-Dependent Transcription by Triggering Signal-Induced SnoN Degradation

  2007cited by this paper
• Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression

  2007cited by this paper
• Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.

  2007cited by this paper
• Signaling in Ovarian Cancer β Factor-That Contribute to the Inhibition of Transforming Growth Expression Profiling Identifies Altered Expression of Genes

  2006cited by this paper
• Sumoylated SnoN Represses Transcription in a Promoter-specific Manner*

  2006cited by this paper
• SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers

  2006cited by this paper
• Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.

  2006cited by this paper
• Dual Role of SnoN in Mammalian Tumorigenesis

  2006influential reference
• Oncogene-induced senescence: putting the brakes on tumor development.

  2006cited by this paper
• Role of transforming growth factor Beta in human cancer.

  2005influential reference
• Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.

  2005cited by this paper
• BRAFE600-associated senescence-like cell cycle arrest of human naevi

  2005cited by this paper
• Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.

  2005cited by this paper
• SKI pathways inducing progression of human melanoma

  2005cited by this paper
• Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.

  2005cited by this paper
• SnoN is a cell type-specific mediator of transforming growth factor-beta responses.

  2005cited by this paper
• Requirement for the SnoN Oncoprotein in Transforming Growth Factor β-Induced Oncogenic Transformation of Fibroblast Cells

  2005influential reference
• Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.

  2005cited by this paper
• SnoN Is a Cell Type-specific Mediator of Transforming Growth Factor-β Responses*

  2005cited by this paper
• PML nuclear bodies: dynamic sensors of DNA damage and cellular stress

  2004cited by this paper
• Amplification of SKI is a prognostic marker in early colorectal cancer.

  2004cited by this paper
• Crystal structure of the dachshund homology domain of human SKI.

  2004cited by this paper
• Increased expression of c‐Ski as a co‐repressor in transforming growth factor‐β signaling correlates with progression of esophageal squamous cell carcinoma

  2004cited by this paper
• Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.

  2004cited by this paper
• SUMO: a regulator of gene expression and genome integrity

  2004cited by this paper
• Smurf2 up-regulation activates telomere-dependent senescence.

  2004cited by this paper
• Tumor cell senescence in cancer treatment.

  2003cited by this paper
• Identification of ZASC1 encoding a Krüppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas.

  2003cited by this paper
• Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.

  2003influential reference
• Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas.

  2003cited by this paper
• Breast cancer in young women (≤35 years): Genomic aberrations detected by comparative genomic hybridization

  2003cited by this paper
• Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.

  2003cited by this paper
• The Transforming Activity of Ski and SnoN Is Dependent on Their Ability to Repress the Activity of Smad Proteins*

  2003cited by this paper
• Proteasomal activity modulates TGF‐ß signaling in a gene‐specific manner

  2002cited by this paper
• Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.

  2002cited by this paper
• Markers of senescence?

  2002cited by this paper
• Investigations for Fine Mapping of Amplifications in Chromosome 3q26.3–28 Frequently Occurring in Squamous Cell Carcinomas of the Head and Neck

  2002cited by this paper
• Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.

  2001cited by this paper
• Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.

  2001cited by this paper
• Ski/Sno and TGF-β signaling

  2001cited by this paper
• Assembly of microarrays for genome-wide measurement of DNA copy number

  2001cited by this paper
• Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice

  2001cited by this paper
• Transforming Growth Factor-β Receptor Type I Gene Is Frequently Mutated in Ovarian Carcinomas

  2001cited by this paper
• Ski/Sno and TGF-beta signaling.

  2001cited by this paper
• TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion.

  2001cited by this paper
• SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus.

  2001cited by this paper
• Mutation analysis of the Smad6 and Smad7 gene in human ovarian cancers.

  2000cited by this paper
• The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice

  2000cited by this paper
• Replicative Senescence and Oxidant‐Induced Premature Senescence: Beyond the Control of Cell Cycle Checkpoints

  2000cited by this paper
• Novel amplification unit at chromosome 3q25–q27 in human prostate cancer

  2000cited by this paper
• Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung.

  2000cited by this paper
• PIK3CA is implicated as an oncogene in ovarian cancer

  1999influential reference
• Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein

  1999cited by this paper
• Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.

  1999cited by this paper
• Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer

  1999cited by this paper
• Mutation analysis of the Smad3 gene in human ovarian cancers.

  1999cited by this paper
• Induction of the PML protein by interferons in normal and APL cells.

  1995cited by this paper
• Transforming growth factor‐beta inhibits proliferation of human ovarian cancer cells obtained from ascites

  1994cited by this paper
• © 1999 Cancer Research Campaign Article no. bjoc.1998.0278 Prognostic significance of urokinase (uPA) and its

  year unknowncited by this paper

• RNA-binding protein FXR1 drives cMYC translation by mRNA circularization through eIF4F recruitment in ovarian cancer

  2020cites this paper
• Proteomics advances for precision therapy in ovarian cancer

  2019cites this paper
• Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease

  2018influential citation
• Exploring New Molecular Targets in Advanced Ovarian Cancer: The Aryl Hydrocarbon Receptor (AhR) and Antitumor Benzothiazole Ligands as Potential Therapeutic Candidates

  2018cites this paper
• BMP-7 enhances SnoN mRNA expression in renal tubular epithelial cells under high-glucose conditions

  2017cites this paper
• Gene Expression Profiling and the Role of HSF1 in Ovarian Cancer in 3D Spheroid Models

  2016cites this paper
• Roles and regulation of phospholipid scramblases

  2015cites this paper
• Induction of PLSCR1 in a STING/IRF3-Dependent Manner upon Vector Transfection in Ovarian Epithelial Cells

  2015cites this paper
• The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells

  2015cites this paper
• Genomic Aberrations at the 3q and 14q loci: Investigation of Key Players in Ovarian and Renal Cancer Biology

  2015influential citation
• Role and Regulation of SnoN/SkiL and PLSCR1 Located at 3q26.2 and 3q23, Respectively, in Ovarian Cancer Pathophysiology

  2014influential citation
• TGFSignaling in Ovarian Cancer

  2014cites this paper
• Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.

  2014cites this paper
• Phospholipid Scramblase 1, an interferon-regulated gene located at 3q23, is regulated by SnoN/SkiL in ovarian cancer cells

  2013cites this paper
• Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer

  2013cites this paper
• SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells.

  2013cites this paper
• Expression Profiles of SnoN in Normal and Cancerous Human Tissues Support Its Tumor Suppressor Role in Human Cancer

  2013cites this paper
• SnoN/SkiL expression is modulated via arsenic trioxide‐induced activation of the PI3K/AKT pathway in ovarian cancer cells

  2013influential citation
• Dysregulated TGFB Signaling in Ovarian Cancer

  2012cites this paper
• Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B

  2012cites this paper
• SnoN signaling in proliferating cells and postmitotic neurons

  2012influential citation
• Pathway crosstalk analysis based on protein-protein network analysis in ovarian cancer.

  2012cites this paper
• Abortive Autophagy Induces Endoplasmic Reticulum Stress and Cell Death in Cancer Cells

  2012cites this paper
• Optimization of Bio-Impedance Sensor for Enhanced Detection and Characterization of Adherent Cells

  2012cites this paper
• Suppression of p53 Activity through the Cooperative Action of Ski and Histone Deacetylase SIRT1*

  2010cites this paper
• Regulation of Claudin-1 Expression Via Activation of Ron Tyrosine Kinase and Transforming Growth Factor-Beta Signaling Pathways in Ovarian Carcinoma

  2010cites this paper
• ARSENIC TRIOXIDE INDUCES A BECLIN-1 INDEPENDENT AUTOPHAGIC PATHWAY VIA MODULATION OF SNON/SKIL EXPRESSION IN OVARIAN CARCINOMA CELLS

  2010cites this paper
• SnoN: bridging neurobiology and cancer biology.

  2010influential citation
• Evaluation of EVI1 and EVI1s (Delta324) as potential therapeutic targets in ovarian cancer.

  2010cites this paper
• The ubiquitin–proteasome system and assays to determine responses to inhibitors

  2010cites this paper
• Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: A role in ovarian pathogenesis

  2008cites this paper
• Regulation of Claudin-1 Expression Via Activation of Ron Tyrosine Regulation of Claudin-1 Expression Via Activation of Ron Tyrosine Kinase and Transforming Growth Factor-Beta Signaling Pathways Kinase and Transforming Growth Factor-Beta Signaling Pathways in Ovarian Carcinoma in Ovarian Carcinoma

  year unknowncites this paper